NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001983

Registered date:19/05/2009

Efficacy of Pranlukast on Stepped Down Treatment for well-controlled patients with mild persistent asthma.

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedasthma
Date of first enrollment2009/04/01
Target sample size60
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)pranlukast, 450mg/day, 6months inhaled corticosteroid, 100mcg/day, 6months

Outcome(s)

Primary Outcomesymptom status of asthma
Secondary Outcomepulmonary function and status of airway inflammation after 2, 4, 6 months treatment period

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1. under 20 years old 2. additional usage of other drugs provided in protocol 3. patients for contraindication 4. patients with malignant tumor 5. pregnant women

Related Information

Contact

public contact
Name Ryo Atsuta
Address 2-1-1 Hongo, Bunkyo-ku, Tokyo, JAPAN Japan
Telephone 03-5802-1063
E-mail atsuta@juntendo.ac.jp
Affiliation Juntendo University school of medicine Department of respiratory medicine
scientific contact
Name kazuhisa Takahashi
Address 2-1-1 Hongo, Bunkyo-ku, Tokyo, JAPAN Japan
Telephone 03-5802-1063
E-mail kztakaha@juntendo.ac.jp
Affiliation Juntendo University school of medicine Department of respiratory medicine